Research location
Butner
North Carolina, United States
Advertisement
Research activity in Butner
North Carolina, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 30 trials and 30 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Butner
30 linked trials · page 1 of 1A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) TherapyNCT02864251 · 2017-03-17 · 1 site observation
COMPLETED
Once-Daily Asenapine for SchizophreniaNCT01549041 · 2012-04-01 · 1 site observation
COMPLETED
A Comparison of Long-acting Injectable Medications for SchizophreniaNCT01136772 · 2011-03-01 · 1 site observation
COMPLETED
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneNCT01173874 · 2010-07-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of GSK239512 in SchizophreniaNCT01009060 · 2009-12-01 · 1 site observation
COMPLETED
Pharmacodynamic/Pharmacokinetic Study of AQW051 in SchizophreniaNCT00825539 · 2009-01-01 · 1 site observation
COMPLETED
Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaNCT00802100 · 2008-12-01 · 1 site observation
COMPLETED
Cardio Risk of Acute Schizophrenia Olanzapine DukeNCT00672464 · 2008-04-01 · 1 site observation
WITHDRAWN
Study Evaluating Vabicaserin in Subjects With SchizophreniaNCT00563706 · 2007-12-01 · 1 site observation
COMPLETED
Metabolic Signatures and Biomarkers in SchizophreniaNCT00466310 · 2007-02-01 · 1 site observation
COMPLETED
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderNCT00423878 · 2007-01-01 · 1 site observation
COMPLETED
Study Evaluating Bifeprunox in Patients With Schizophrenia.NCT00366327 · 2007-01-01 · 1 site observation
TERMINATED
Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointNCT00366704 · 2006-11-01 · 1 site observation
TERMINATED
Open Label Extension Study of BifeprunoxNCT00366171 · 2006-11-01 · 1 site observation
COMPLETED
Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.NCT00380224 · 2006-07-01 · 1 site observation
COMPLETED
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With RisperdalNCT00314613 · 2006-04-01 · 1 site observation
TERMINATED
High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia SymptomsNCT00403546 · 2006-01-01 · 1 site observation
COMPLETED
SB-773812 Administered In Adults With SchizophreniaNCT00259870 · 2005-09-01 · 1 site observation
COMPLETED
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsNCT00097942 · 2004-08-01 · 1 site observation
COMPLETED
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsNCT00634348 · 2004-04-01 · 1 site observation
COMPLETED
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete AdherenceNCT00215579 · 2004-04-01 · 1 site observation
COMPLETED
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderNCT00100776 · 2003-09-01 · 1 site observation
COMPLETED
Clinical Study Of Schizophrenia in Both Men and WomenNCT00071747 · 2003-08-01 · 1 site observation
COMPLETED
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of SchizophreniaNCT00073164 · 2003-07-01 · 1 site observation
COMPLETED
High Intensity Light Therapy in Alzheimer's DiseaseNCT00065689 · 2003-03-01 · 1 site observation
COMPLETED
Schizophrenia Study In AdultsNCT00049946 · 2002-10-01 · 1 site observation
COMPLETED
CAFE Comparison of Atypicals in First Episode of PsychosisNCT00034892 · 2002-03-01 · 1 site observation
COMPLETED
A Comparison of Seroquel vs. Risperidone in SchizophreniaNCT00034905 · 2001-07-01 · 1 site observation
COMPLETED
CATIE- Schizophrenia TrialNCT00014001 · 2000-12-01 · 1 site observation
COMPLETED
A Combination of Two Currently Approved Drugs to Enhance the Treatment of SchizophreniaNCT00089869 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.